Buscar
Mostrando ítems 71-80 de 14191
Paracoccidioidomycosis: epidemiological, clinical, diagnostic and treatment up-dating
(Soc Brasileira Dermatologia, 2014)
Time to initiation of multidrug-resistant tuberculosis treatment and its relation with outcome in a high incidence district in Lima, Peru
(Wiley, 2015)
Objective: To determine the time from diagnosis to start of multidrug resistant tuberculosis (MDR TB) treatment in Lima, Peru. Methods: We studied new smear-positive TB adults that were started on MDR TB treatment or that ...
The CROWN initiative: journal editors invite researchers to develop core outcomes in women’s health
(BioMed Central, 2014-07)
Clinical trials, systematic reviews and guidelines compare beneficial and non-beneficial outcomes following interventions. Often, however, various studies on a particular topic do not address the same outcomes, making it ...
Standardised Outcomes in Nephrology - Chronic Kidney Disease (SONG-CKD): a protocol for establishing a core outcome set for adults with chronic kidney disease who do not require kidney replacement therapy
(BMC, 2021)
Background: Globally, over 1.2 million people die from chronic kidney disease (CKD) every year. Patients with CKD are up to 10 times more likely to die prematurely than progress to kidney failure requiring kidney replacement ...
Rectovaginal fistula with anal atresia in 5 dogs
(2007-08-01)
Five dogs with rectovaginal fistula and atresia ani that had been treated by surgical correction of the malformations were studied retrospectively. Ages at presentation varied from 1 to 3 months and weight from 350 g to ...
Rectovaginal fistula with anal atresia in 5 dogs
(2007-08-01)
Five dogs with rectovaginal fistula and atresia ani that had been treated by surgical correction of the malformations were studied retrospectively. Ages at presentation varied from 1 to 3 months and weight from 350 g to ...
Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014
(Public Library of Science, 2018)
Background: Resistance to isoniazid is the most common form of drug-resistance in tuberculosis. However only a tiny proportion of TB patients in the world have access to isoniazid drug susceptibility testing—the widely ...